500 patients67,039 observations150 daysLIVE

Patient P-03389

Synthetic patientONX-7 · Day 140 · 45–54 · F · baseline S01Open companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Stable
Discontinuation risk
32%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S01
  2. Day 15 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • GI instability+9
  • Inflammatory activity+9
  • Nutritional resilience-3
  • Toxicity+3
  • Treatment adherence-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients.

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production 60
      • MicrobiomeButyrate capacity 27/100
      • MicrobiomeF. prausnitzii depleted
    • Drug metabolism and exposure 35
      • DNADPYD *2A → slower clearance
    • Mucosal barrier integrity 30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Autonomic recovery 20
      • Wearable3,814 steps/day
    DNA
    Fictional pharmacogenomic panel
    • DPYD *2A heterozygous
      Slower drug clearance
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.3 · butyrate capacity 27/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    49 ms
    Sleep
    6.5 h
    Steps
    3,372
    Resting HR
    62 bpm
    Daily log: GI score 33, nutritional resilience 55, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0348449%S07DT-01improved49
    P-0317948%S05GI-04improved52
    P-0325547%S01HY-01improved53
    P-0337547%S09DT-01improved52
    P-0320445%S16AD-05improved48
    P-0314444%S16HY-01improved52
    P-0339242%S15GI-04improved52
    P-0340842%S09HY-01improved53
    P-0344242%S11DT-01improved51
    P-0326841%S15DT-01improved56
    P-0319340%S13DT-01improved53
    P-0323340%S19DT-01improved47